Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation

Sinusoidal Obstruction Syndrome (SOS) is a life threatening HSCT complication and it can rapidly evolve in Multiple Organ Dysfunction Syndrome, with a mortality exceeding 80%. Early treatment with defibrotide is the leading factor for efficacy. Its prophylactic use is recommended in the pediatric se...

Descripción completa

Detalles Bibliográficos
Autores principales: Giglio, Fabio, Xue, Elisabetta, Greco, Raffaella, Lazzari, Lorenzo, Clerici, Daniela Teresa, Lorentino, Francesca, Mastaglio, Sara, Marktel, Sarah, Lupo-Stanghellini, Maria Teresa, Marcatti, Magda, Corti, Consuelo, Bernardi, Massimo, Piemontese, Simona, Ciceri, Fabio, Peccatori, Jacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240310/
https://www.ncbi.nlm.nih.gov/pubmed/35785209
http://dx.doi.org/10.3389/fonc.2022.933317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240310/
https://www.ncbi.nlm.nih.gov/pubmed/35785209
http://dx.doi.org/10.3389/fonc.2022.933317

Ejemplares similares